Results 131 to 140 of about 2,635,424 (241)

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.

open access: yesNew England Journal of Medicine, 2005
P. Richardson   +20 more
semanticscholar   +1 more source

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

open access: yesNew England Journal of Medicine, 2014
O. Chinot   +13 more
semanticscholar   +1 more source

Which matters more for preventing knee replacements: reducing overactivity or combating inactivity? [PDF]

open access: yesAging Clin Exp Res
Kanai M   +6 more
europepmc   +1 more source

A phase 2 study of bortezomib in relapsed, refractory myeloma.

open access: yesNew England Journal of Medicine, 2003
P. Richardson   +20 more
semanticscholar   +1 more source

Improved survival with MEK inhibition in BRAF-mutated melanoma.

open access: yesNew England Journal of Medicine, 2012
K. Flaherty   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy